Skip to main content

Peer Review reports

From: Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Original Submission
28 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
28 Jul 2016 Editorially accepted
18 Aug 2016 Article published 10.1186/s12885-016-2642-1

You can find further information about peer review here.

Back to article page